Write your message
Volume 7, Issue 4 (July & August 2022)                   J Obstet Gynecol Cancer Res 2022, 7(4): 348-350 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikhhasani S, Peydayesh M, Zamani N, Nikfar S, Mohseni M. PEComa of the Ovary: A Case Report. J Obstet Gynecol Cancer Res. 2022; 7 (4) :348-350
URL: http://jogcr.com/article-1-393-en.html
1- Department of Oncologic Gynecology, Vali-e Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Gynecology, School of Medicine, Pasteur Hospital, Bam University of Medical Sciences , drpeydayesh57@gmail.com
3- Department of Obstetrics and Gynecology, School of Medicine, Taleghani Hospital, Arak University of Medical Sciences, Arak, Iran
Full-Text [PDF 227 kb]   (59 Downloads)     |   Abstract (HTML)  (556 Views)
Full-Text:   (27 Views)

Perivascular epithelioid cell tumors (PEComas) are a group of mesenchymal neoplasms with a different biological presentation from benign to malignant types (1). The PEComas neoplasms include angiomyolipoma (AML), lymphangioma, the falciform ligament teres clear cell myomelanocytic tumor, as well as other tumors with the same features at different organs (2).
Although due to its rarity, the most common anatomic location with PEComa has not been accu-rately determined, the genitourinary tract, especially the uterus and kidney, were the most frequent site of PEComa in previously reported cases (3-5)
On the other hand, the clinical presentation of PEComa is not well recognized; spontaneous hemop-eritoneum in pregnancy (6), mild abdominal disco-mfort (1), intermittent lower abdominal pain, and vaginal bleeding (2) are some examples of PEComa clinical features.
Hence, herein we report the first description of PEComa presenting with an acute surgical abdomen. The patient's definite diagnoses were made based on the histomorphology results at Imam Khomeini Hospital, Tehran University of Medical Sciences, in 2020.


Case Report

A previously healthy 32-year-old virgin single woman with a chief complaint about acute severe abdominal pain was referred to Imam Khomeini Hospital's emergency department, Tehran, Iran. Her physical examination and laboratory findings were unremarkable.
Ultrasound examination showed hypovascular and solid tumor 9×9×18 cm in the right adnexal with huge ascites. CT scan of the abdomen revealed severe ascites, hypodense lesion 5×5 cm in liver, solid cystic mass in right ovary, multiple omental and peritoneal tumor maximally 5 cm near liver (Figure 1A, B).
Furthermore, the thorax CT scan detected three small nodules (3mm/3mm/4mm) in the left lung with mild pleural effusion on the right side. Her tumor marker tests showed an elevated serum CA125 concentration up to 557 U/mL, and the other tumor markers were within normal limits.
Intraoperative findings revealed a huge amount of bloody ascites (six liters). There was a 20×12 cm solid hemorrhagic cystic tumor in the right adnexal tumor with omental involvement. During laparotomy, bilateral salpingo-oophorectomy (due to undifferen-tiated epithelial histology of frozen result in both ovaries), pelvic lymphadenectomy, infra-colic oment-ectomy with uterine preservation were performed.
The post-operation pathology report revealed nests of epithelioid cells by cleared-out cytoplasm and uniform nuclei by mild cytologic atypia. Furthermore, CD99, vimentin, NSE, melan A, C-kit, SAX10, human melanin black-45 (HMB-45), S100 (few scattered), synaptophysin (few scattered) were positive in immunohistochemical (IHC) staining analysis.
According to the above histopathological findings, the diagnosis of a PEComa was made. After cytoreductive surgery, chemotherapy with BEP was immediately initiated. After four cycles of chemo-therapy, the tumor recurred, and the patient was a candidate for the second cytoreductive surgery. Still, she refused and did not refer to the hospital to complete her therapy. After that, we did not know about the detail of her treatment, and unfortunately, her relatives said that she had died.

Figure 1. CT-scan of the abdomen in a 32-year-old female with malignant perivascular epithelioid cell tumors of the ovaries.
Figure 1. CT-scan of the abdomen in a 32-year-old female with malignant perivascular epithelioid cell tumors of the ovaries.



PEComa is a rare tumor with a unique diagnostic challenge that leads to a late diagnosis, similar to our study case (7). However, Knowledge of its specific clinicopathological, imaging, and tumor marker may accelerate the diagnosis of PEComa (8).
It is worth mentioning IHC plays a vital role in its diagnosis. Synchronous melanocytic and smooth muscle marker expression is the hallmark of PEComas. Immunoreactivity for melanocytic markers include HMB-45 and melan A, and myogenic markers consist of smooth muscle actin, desmin, and h-caldesmon (7, 9).
Evidence showed that the peak age for genital tract PEComa incidence is the mid-40 s, although the reported patients with PEComa have had different ages from 9 to 79 years (2). As the study case was 32 years (at the high-risk age), PEComa must be placed as a differential diagnosis in her ovary masses.
Although most PEComas behave as benign tumors, a few of these will be malignant. The characteristics of invasive tumors were indicated in former studies; the size of the tumor (greater than 5 cm), histological features, necrosis, and invasion to vessels are some of these predictor factors to malignancy (10).
Because of rare cases reported and lack of clinical trial, the proper therapy for PEComa in the female genital tract is not available. There is only a strong consensus about tumor-free margin cytoreduction as a primary treatment, and chemotherapy and radio-therapy's usefulness is ambiguous. Recently, targeted therapies such as mTOR inhibitor usage seem to have promising results (2, 11, 12).



Considering different clinical presentations, unkn-own characteristics of imaging, and rarity of PEComa, preoperative diagnosis of it seems impossible. However, IHC can play an important role in its diagnosis.





Conflicts of Interest

The authors declared no conflict of interests.


Systematic Review: Case Report | Subject: Gynecology Oncology
Received: 2021/05/8 | Accepted: 2021/07/13 | Published: 2022/03/14

1. Yoo-Bee H, Ri SY, Jun KK, Jiyoung K. Computerized Tomography and Magnetic Resonance Imaging Findings in Malignant Perivascular Epithelioid Cell Tumors of the Ovaries with Pulmonary Metastasis. Iran J Radiol. 2016 Aug 1;13(4):e34712. [DOI:10.5812/iranjradiol.34712] [PMID] [PMCID]
2. Liu CH, Chao WT, Lin SC, Lau HY, Wu HH, Wang PH. Malignant perivascular epithelioid cell tumor in the female genital tract: Preferred reporting items for systematic reviews and meta-analyses. Medicine (Baltimore). 2019;98(2):e14072. [DOI:10.1097/MD.0000000000014072] [PMID] [PMCID]
3. Tirumani SH, Shinagare AB, Hargreaves J, Jagannathan JP, Hornick JL, Wagner AJ, et al. Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors. Am J Roentgenol. 2014;202(2):252-8. [DOI:10.2214/AJR.13.10909] [PMID]
4. Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005; 29:1558-75 [DOI:10.1097/01.pas.0000173232.22117.37] [PMID]
5. Jeon IS, Lee SM. Multimodal treatment using surgery, radiotherapy, and chemotherapy in a patient with a perivascular epithelioid cell tumor of the uterus. J Pediatr Hematol Oncol 2005; 27(12):681-4. [DOI:10.1097/01.mph.0000193475.06870.d5] [PMID]
6. Nitahara K, Sasaki M, Ichikawa S, Tsuji K, Yoshida Y. Rupture of perivascular epithelioid cell neoplasm at 34 weeks' gestation: A nonendometriosis case of spontaneous hemoperitoneum in pregnancy. J Obstet Gynaecol Res. 2019;45(3):709-13. [DOI:10.1111/jog.13870] [PMID]
7. Westaby JD, Magdy N, Fisher C, El-Bahrawy M. Primary Ovarian Malignant PEComa: A Case Report. Int J Gynecol Pathol. 2017 Jul;36(4):400-4. [DOI:10.1097/PGP.0000000000000331] [PMID]
8. Tan Y, Zhang H, Xiao EH. Perivascular epithelioid cell tumour: dynamic CT, MRI and clinicopathological characteristics--analysis of 32 cases and review of the literature. Clin Radiol. 2013 Jun;68(6):555-61. [DOI:10.1016/j.crad.2012.10.021] [PMID]
9. Pant L, Kalita D, Chopra R, Das A, Jain G. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Adrenal Gland: Report of a Rare Case Posing Diagnostic Challenge with the Role of Immunohistochemistry in the Diagnosis. Endocr Pathol. 2015 May;26(2):129-34. [DOI:10.1007/s12022-015-9360-0] [PMID]
10. Westaby JD, Magdy N, Fisher C, et al. Primary ovarian malignant PEComa: a case report. Int J Gynecol Pathol 2017;36(4):400-4. [DOI:10.1097/PGP.0000000000000331] [PMID]
11. Wagner AJ, Malinowska-Kolodziej I, Morgan JA, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol. 2010; 28:835-40. [DOI:10.1200/JCO.2009.25.2981] [PMID] [PMCID]
12. Schoolmeester JK, Howitt BE, Hirsch MS, Dal Cin P, Quade BJ, Nucci MR. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol. 2014 Feb;38(2):176-88. [DOI:10.1097/PAS.0000000000000133] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.